Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer

NCT05052853 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Prodromal Schizophrenia

Interventions

DRUG: NMDAE
DRUG: Placebo Cap

Sponsor

China Medical University Hospital